Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues

Bioconjugate Chemistry
Kwamena E BaidooH N Wagner

Abstract

Potent antagonists of bombesin-like peptides have shown great potential for applications in cancer therapy. A 99mTc-labeled agent capable of identifying patients who could benefit from these emerging therapies would have a great impact on patient management. This study involves the synthesis and initial evaluation of technetium diaminedithiolate analogues derived from the potent bombesin analogue Pyr-Gln-Lys-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 (Lys3-bombesin). We coupled two diaminedithiol (DADT) bifunctional chelating agents (BCAs 1 and 2) to the Lys3 residue at the N-terminal region that is not required for binding to the receptor. 99mTc labeling was performed by ligand exchange on addition of [99mTc]glucoheptonate to a solution of the adduct at room temperature. Two products were obtained from each adduct on analysis by HPLC. The major to minor product ratios of the 99mTc-labeled analogues were 3:1 for products from BCA 1 and 9:1 for the products from BCA 2. Macroscopic amounts of the 99Tc analogues were similarly prepared using [99Tc]glucoheptonate. In this case, the major to minor ratios were 2:1 for the products from both BCAs. For initial evaluation of the binding of the Tc-labeled peptides to bombesin recept...Continue Reading

References

May 15, 1988·Acta Crystallographica. Section C, Crystal Structure Communications·R FaggianiD Brune
Nov 1, 1985·Journal of Pharmacological Methods·G A McPherson
May 3, 1984·Nature·R T JensenJ D Gardner

❮ Previous
Next ❯

Citations

Jan 31, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Hanwen ZhangHelmut R Maecke
Mar 6, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Peter LavermanWim J G Oyen
Sep 26, 2009·Targeted Oncology·Rafael Torres Martin de RosalesPhilip J Blower
Nov 16, 2002·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Ronald E Weiner, Mathew L Thakur
Aug 23, 2001·Nuclear Medicine and Biology·T J HoffmanW A Volkert
Dec 31, 2003·Nuclear Medicine and Biology·C J SmithT J Hoffman
Jul 26, 2002·Cancer Biotherapy & Radiopharmaceuticals·A D VarvarigouS C Archimandritis
Jun 10, 2004·Cancer Biotherapy & Radiopharmaceuticals·Alexandra VarvarigouGiuseppe De Vincentis
Jun 10, 2004·Cancer Biotherapy & Radiopharmaceuticals·Hans-Jürgen WesterMarkus Schwaiger
Apr 8, 2004·Cancer Biotherapy & Radiopharmaceuticals·Buck E RogersAhmad Safavy
Jun 30, 2011·Cancer Biotherapy & Radiopharmaceuticals·Seyed Pezhman ShirmardiMojtaba Shamsaei
Mar 10, 2001·Nuclear Medicine Communications·C Van de WieleR A Dierckx
Mar 15, 2006·Nuclear Medicine Communications·Guillermina Ferro-FloresMaría Teresa Ramírez-Iglesias
Nov 14, 2006·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Theodosia MainaStephen Mather
Jun 23, 2009·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·Amanda L MartinElizabeth R Gillies
Mar 31, 2012·International Journal of Pharmaceutics·Christos C LioliosGregory B Sivolapenko
Feb 7, 2012·Revista española de medicina nuclear e imagen molecular·A Hernández-CairoC Casacó-Santana
Jun 29, 2010·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·G Ferro-FloresD Ordaz-Rosado
Apr 28, 2009·International Journal of Pharmaceutics·Clara L Santos-CuevasDavid Ordaz-Rosado
Nov 7, 2015·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Liliana Aranda-LaraKeila Isaac-Olivé
Jan 14, 2003·Seminars in Nuclear Medicine·Josef MachacChun Kim
Nov 17, 2001·Seminars in Nuclear Medicine·R E Weiner, M L Thakur
Aug 6, 2000·Seminars in Nuclear Medicine·O C BoermanF H Corstens
Oct 26, 2005·Nuclear Medicine and Biology·Charles J SmithTimothy J Hoffman
Oct 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jie XiaoDengfeng Cheng
Feb 26, 2016·Natural Product Reports·C L CharronL G Luyt
Mar 20, 2013·Nature Reviews. Urology·Rosalba MansiJean C Reubi
Aug 30, 2008·Nuclear Medicine Communications·Clara L Santos-CuevasPablo A Pichardo-Romero
Jun 30, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ronald E Weiner, Mathew L Thakur
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Sep 10, 2014·Journal of Labelled Compounds & Radiopharmaceuticals·Nallely Jiménez-MancillaEugenio Torres-García
Feb 6, 2020·Pharmaceuticals·Christine Rangger, Roland Haubner
Nov 4, 2000·International Journal of Cancer. Journal International Du Cancer·A PlonowskiG Halmos
Dec 15, 2015·Nuclear Medicine Communications·Liliana Aranda-LaraKeila Isaac-Olivé
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jörg B EngelAttila Nagy
Aug 23, 2017·Seminars in Nuclear Medicine·Isaac M JacksonStephen Thompson
Dec 26, 2001·Chemical Reviews·S Liu, D S Edwards
Dec 22, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michael M Graham, Yusuf Menda
Sep 11, 2002·Inorganic Chemistry·Katerina ChryssouChariklia I Stassinopoulou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.